FDA: Johnson & Johnson's one-shot vaccine prevents COVID; final decision soon
A final decision could come as early as Friday.
Johnson & Johnson’s single-dose vaccine protects against COVID-19, federal regulators said Wednesday, paving the way for a final approval as early as this week.
The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot – which could help speed vaccinations by requiring just one dose instead of two – is safe to use, according to the Associated Press.
That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S.
On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot, the wire service also reports.
News, Not Noise
- Sen. Rand Paul says Dr. Anthony Fauci is an elitist who 'thinks he's smarter than the rest of us'
- Sen. Ted Cruz says Biden's comments on Chauvin trial supplied grounds for mistrial
- Merkel says she criticizes Putin 'directly,' after Biden admits on TV he thinks he's a 'killer'
- Columnist, pundit Juan Williams says TV show host rejected him for not being 'black enough'
- Ocasio-Cortez: House GOP censuring Waters 'because they don't have any ideas of their own'